| Emad Al Haj Ali, MD | |
|
736 Cambridge St, St. Margaret Center. 8th Floor, Brighton, MA 02135 | |
| (617) 779-6441 | |
| Not Available |
| Full Name | Emad Al Haj Ali |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 17 Years |
| Location | 736 Cambridge St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700340932 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pleasant Valley Hospital | Point pleasant, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Point Pleasant Physician Billing Services | 3375538184 | 29 |
News Archive
The spike protein is the main part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the infection. It consists of two subunits S1 and S2. Upon entry of the virus into the human body, the S1 subunit helps the virus bind to the angiotensin-converting enzyme 2 (ACE2) receptors on host cells.
A group of Italian researchers headed by Prof. Giovanni Fava (University of Bologna) has published a multicenter investigation on demoralization in the setting of medical disease. Demoralization was defined according to diagnostic criteria encompassing unpleasant, distressing feelings of personal failure and inadequacies, with a loss of continuity in the sense of sequence between past and future.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended March 31, 2014.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
› Verified 8 days ago
| Entity Name | Point Pleasant Physician Billing Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
The spike protein is the main part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the infection. It consists of two subunits S1 and S2. Upon entry of the virus into the human body, the S1 subunit helps the virus bind to the angiotensin-converting enzyme 2 (ACE2) receptors on host cells.
A group of Italian researchers headed by Prof. Giovanni Fava (University of Bologna) has published a multicenter investigation on demoralization in the setting of medical disease. Demoralization was defined according to diagnostic criteria encompassing unpleasant, distressing feelings of personal failure and inadequacies, with a loss of continuity in the sense of sequence between past and future.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended March 31, 2014.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emad Al Haj Ali, MD 35423 Hickory Green Ct Apt B, Westland, MI 48185-6674 Ph: (469) 767-1748 | Emad Al Haj Ali, MD 736 Cambridge St, St. Margaret Center. 8th Floor, Brighton, MA 02135 Ph: (617) 779-6441 |
News Archive
The spike protein is the main part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the infection. It consists of two subunits S1 and S2. Upon entry of the virus into the human body, the S1 subunit helps the virus bind to the angiotensin-converting enzyme 2 (ACE2) receptors on host cells.
A group of Italian researchers headed by Prof. Giovanni Fava (University of Bologna) has published a multicenter investigation on demoralization in the setting of medical disease. Demoralization was defined according to diagnostic criteria encompassing unpleasant, distressing feelings of personal failure and inadequacies, with a loss of continuity in the sense of sequence between past and future.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended March 31, 2014.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
› Verified 8 days ago
Dr. Niranjan Sritharan, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Michael Schlewet, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Smc-8, Brighton, MA 02135 Phone: 617-779-6441 | |
Hussam Tallab, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, St. Elizabeth Department Of Otolaryngology, Brighton, MA 02135 Phone: 617-779-6441 | |
Ayham Alkarmi, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-779-6441 | |
Yusuf M. Gulleth, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge Street, Smc 8, Brighton, MA 02135 Phone: 617-789-5004 Fax: 617-789-5088 | |
Dr. Meera Gopu, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Dr. Yogesh Indrasen More, M.D Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, St Elizabeth's Hospital, Otolaryngology, Smc 8, Brighton, MA 02135 Phone: 617-779-6445 Fax: 617-789-5088 |